K2M Group Holdings, Inc. (KTWO) Rating Reiterated by JMP Securities

K2M Group Holdings, Inc. (NASDAQ:KTWO)‘s stock had its “outperform” rating restated by equities research analysts at JMP Securities in a note issued to investors on Tuesday. They presently have a $25.00 price objective on the medical device company’s stock, down from their prior price objective of $30.00. JMP Securities’ price objective would indicate a potential upside of 38.81% from the company’s current price.

A number of other brokerages have also commented on KTWO. Royal Bank Of Canada reissued a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a report on Thursday, July 20th. BidaskClub raised shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th. Cowen and Company reissued a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, July 19th. Needham & Company LLC restated a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the company a “buy” rating in a research report on Wednesday, August 2nd. One analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $25.60.

K2M Group Holdings (NASDAQ:KTWO) traded up 1.35% during mid-day trading on Tuesday, hitting $18.01. 1,710,341 shares of the company’s stock were exchanged. K2M Group Holdings has a 52 week low of $16.32 and a 52 week high of $25.99. The stock’s market capitalization is $779.26 million. The firm has a 50 day moving average of $22.10 and a 200 day moving average of $22.53.

K2M Group Holdings (NASDAQ:KTWO) last issued its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The firm had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. During the same quarter in the prior year, the firm earned ($0.27) EPS. The company’s revenue was up 11.0% on a year-over-year basis. Equities analysts forecast that K2M Group Holdings will post ($0.81) earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://ledgergazette.com/2017/10/10/k2m-group-holdings-inc-ktwo-rating-reiterated-by-jmp-securities.html.

In related news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now directly owns 55,158 shares in the company, valued at approximately $1,328,204.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $26,247.20. Following the completion of the sale, the insider now owns 201,961 shares in the company, valued at $4,863,220.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 44,129 shares of company stock worth $1,033,644. Corporate insiders own 5.80% of the company’s stock.

Large investors have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA raised its position in shares of K2M Group Holdings by 5,175.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock valued at $109,000 after acquiring an additional 4,399 shares during the period. Legal & General Group Plc raised its position in shares of K2M Group Holdings by 9.1% in the 1st quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after acquiring an additional 564 shares during the period. Dorsey & Whitney Trust CO LLC acquired a new stake in shares of K2M Group Holdings in the 2nd quarter valued at approximately $211,000. American International Group Inc. raised its position in shares of K2M Group Holdings by 7.1% in the 1st quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after acquiring an additional 1,047 shares during the period. Finally, Symphony Asset Manag

A number of other brokerages have also commented on KTWO. Royal Bank Of Canada reissued a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a report on Thursday, July 20th. BidaskClub raised shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th. Cowen and Company reissued a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, July 19th. Needham & Company LLC restated a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the company a “buy” rating in a research report on Wednesday, August 2nd. One analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $25.60.

K2M Group Holdings (NASDAQ:KTWO) traded up 1.35% during mid-day trading on Tuesday, hitting $18.01. 1,710,341 shares of the company’s stock were exchanged. K2M Group Holdings has a 52 week low of $16.32 and a 52 week high of $25.99. The stock’s market capitalization is $779.26 million. The firm has a 50 day moving average of $22.10 and a 200 day moving average of $22.53.

K2M Group Holdings (NASDAQ:KTWO) last issued its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The firm had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. During the same quarter in the prior year, the firm earned ($0.27) EPS. The company’s revenue was up 11.0% on a year-over-year basis. Equities analysts forecast that K2M Group Holdings will post ($0.81) earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://ledgergazette.com/2017/10/10/k2m-group-holdings-inc-ktwo-rating-reiterated-by-jmp-securities.html.

In related news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now directly owns 55,158 shares in the company, valued at approximately $1,328,204.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $26,247.20. Following the completion of the sale, the insider now owns 201,961 shares in the company, valued at $4,863,220.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 44,129 shares of company stock worth $1,033,644. Corporate insiders own 5.80% of the company’s stock.

Large investors have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA raised its position in shares of K2M Group Holdings by 5,175.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock valued at $109,000 after acquiring an additional 4,399 shares during the period. Legal & General Group Plc raised its position in shares of K2M Group Holdings by 9.1% in the 1st quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after acquiring an additional 564 shares during the period. Dorsey & Whitney Trust CO LLC acquired a new stake in shares of K2M Group Holdings in the 2nd quarter valued at approximately $211,000. American International Group Inc. raised its position in shares of K2M Group Holdings by 7.1% in the 1st quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after acquiring an additional 1,047 shares during the period. Finally, Symphony Asset Management LLC acquired a new stake in shares of K2M Group Holdings in the 2nd quarter valued at approximately $351,000. Institutional investors and hedge funds own 97.86% of the company’s stock.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply